Ranbaxy Takes a Hit After Initiating Recall of Atorvastatin Tablets in the US

by Kathy Jones on  November 27, 2012 at 7:05 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

One of India's biggest drug makers, Ranbaxy Laboratories, revealed that it has initiated a recall of its cholesterol-lowering drug Atorvastatin calcium in the United States after finding that some of the batches may contain small amounts of glass.
 Ranbaxy Takes a Hit After Initiating Recall of Atorvastatin Tablets in the US
Ranbaxy Takes a Hit After Initiating Recall of Atorvastatin Tablets in the US

The company said that the recall could lead to temporary disruption in supply of the drug as it may take up to two weeks for it to complete an investigation.

Analysts are also predicting that the recall will hurt the company financially with share prices seeing a 3.1 percent drop on the Indian markets.

"Ranbaxy... is conducting a voluntary recall for Atorvastatin calcium tablets, in connection with its 10 mg, 20 mg and 40 mg dosage strengths... only with respect to certain select lot numbers... The recall is being conducted at the retail level for such select batches that may contain a foreign substance (small glass particles approximately less than 1 mm in size)", the company said in a statement.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive